共 62 条
- [1] Romero P(1998) staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes J Exp Med 188 1641-1650
- [2] Speiser DE(1999) expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes J Exp Med 190 775-782
- [3] Lee PP(1999)Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients Nature Med 5 677-685
- [4] Doyle A(1985)Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer J Exp Med 161 1135-1151
- [5] Banchereau J(1998)Dendritic cells and the control of immunity Nature 392 245-252
- [6] Steinman RM(1997)Dendritic cells as adjuvants for immune-mediated resistance to tumors J Exp Med 186 1183-1187
- [7] Schuler G(1995)Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity Nature Med 1 1297-1302
- [8] Steinman RM(1996)Vaccination of patients with B cell lymphoma using autologous antigen-pulsed dendritic cells Nature Med 2 52-58
- [9] Mayordomo JI(1996)Phase I clinical trial: T cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen Prostate 29 371-380
- [10] Hsu FJ(1998)Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells Nature Med 4 328-332